This one-hour webinar presentation will discuss why oxygen is a physiological problem with interstitial lung disease (ILD) and why supplemental oxygen is recommended. The webinar included important info about portable oxygen containers, how to get involved in oxygen advocacy initiatives, and where to find helpful information and resources.


Sponsored with the generous support of Boehringer Ingelheim, Genentech, a member of the Roche Group, and United Therapeutics.


Social media platforms -
Twitter - @PFFORG
Facebook - @PFFORG
Instagram - @PFFORG
LinkedIn- Pulmonary Fibrosis Foundation


Please note that any information contained in this presentation is for informational and/or educational purposes only. It is not intended to be a substitute for professional medical advice. Always consult your personal physician or health care provider with any questions you may have regarding your specific medical condition.


This presentation is protected by U.S. and International copyright laws. Reproduction and distribution of this presentation without written permission from the Pulmonary Fibrosis Foundation is prohibited.


© 2023 Pulmonary Fibrosis Foundation

свернуть